Prevalence and comorbidities of Sjogren's syndrome patients in the Community of Madrid: A population-based cross-sectional study
•SS prevalence varies widely due to geolocation, studied populations, classification criteria and epidemiologic methodologies.•Disease diagnosis may be delayed, omitted, or misclassified as another rheumatic or nonrheumatic disease.•Health care policies facilitate early diagnosis and improve SS mana...
Gespeichert in:
| Veröffentlicht in: | Joint, bone, spine : revue du rhumatisme bone, spine : revue du rhumatisme, 2023-07, Vol.90 (4), p.105544-105544, Article 105544 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 105544 |
|---|---|
| container_issue | 4 |
| container_start_page | 105544 |
| container_title | Joint, bone, spine : revue du rhumatisme |
| container_volume | 90 |
| creator | Barrio-Cortes, Jaime López-Rodríguez, Juan Antonio Gómez-Gascón, Tomas Rayo-Gómez, Ángeles del Cura-González, Isabel Domínguez-Berjón, Felicitas Esteban-Vasallo, Dolores Chalco-Orrego, Juan Pablo Vicente-Rabaneda, Esther Baldini, Chiara Seghieri, Chiara Goules, Andreas V. Fotiadis, Dimitrios I. Tzioufas, Athanasios G. |
| description | •SS prevalence varies widely due to geolocation, studied populations, classification criteria and epidemiologic methodologies.•Disease diagnosis may be delayed, omitted, or misclassified as another rheumatic or nonrheumatic disease.•Health care policies facilitate early diagnosis and improve SS management and patients’ quality of life.
To estimate the prevalence, sociodemographic characteristics and comorbidities of Sjogren's syndrome (SS) patients in the Community of Madrid.
A population-based cross-sectional cohort of SS patients was derived from the information system for rare diseases in the Community of Madrid (SIERMA) and confirmed by a physician. The prevalence per 10,000 inhabitants among people aged ≥18years in June 2015 was calculated. Sociodemographic data and accompanying disorders were recorded. Univariate and bivariate analyses were performed.
A total of 4,778 SS patients were confirmed in SIERMA; 92.8% were female, with a mean age of 64.3 (standard deviation=15.4) years. A total of 3,116 (65.2%) patients were classified as primary SS (pSS), and 1,662 (34.8%) as secondary SS (sSS). The prevalence of SS among people aged ≥18 years was 8.4/10,000 (95%Confidence interval [CI]=8.2–8.7). The prevalence of pSS was 5.5/10,000 (95%CI=5.3–5.7), and that of sSS was 2.8/10,000 (95%CI=2.7–2.9), with rheumatoid arthritis (20.3%) and systemic lupus erythematosus (8.5%) being the most prevalent associated autoimmune diseases. The most common comorbidities were hypertension (40.8%), lipid disorders (32.7%), osteoarthritis (27.7%) and depression (21.1%). The most prescribed medications were nonsteroidal anti-inflammatory drugs (31.9%), topical ophthalmic therapies (31.2%) and corticosteroids (28.0%).
The prevalence of SS in the Community of Madrid was similar to the overall prevalence worldwide observed in previous studies. SS was more frequent in women in their sixth decade. Two out of every three SS cases were pSS, while one-third were associated predominantly with rheumatoid arthritis and systemic lupus erythematosus. |
| doi_str_mv | 10.1016/j.jbspin.2023.105544 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2829426514</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1297319X23000234</els_id><sourcerecordid>2829426514</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-257b4439279097af55163a90149c979dc379077b70f406b360a60ad3912c2c683</originalsourceid><addsrcrecordid>eNp9kEuL1TAUgIM4OA_9ByLZOZveyTs3LoThMqPCiIIK7kKapJrSJjVpB-7Onz6pHV0KgYRzvvPIB8BLjHYYYXHV7_q2TCHuCCK0hjhn7Ak4w1LuG0k4e1rfRMmGYvX9FJyX0iOEKOHiGTilQirB9_gM_P6c_b0ZfLQemuigTWPKbXBhDr7A1MEvffqRfXxdYDlGl9Po4WRqMs4Fhgjnnx4e0jguMczHlf9oXA7uDbyGU5qWoaIpNq0pvvbOqZSmeLvGzADLvLjjc3DSmaH4F4_3Bfh2e_P18L65-_Tuw-H6rrFUkLkhXLaMUUWkQkqajnMsqFEIM2WVVM7SmpCylahjSLRUIFOPowoTS6zY0wtwufWdcvq1-DLrMRTrh8FEn5aiyZ4oRgTHrKJsQ_8snH2npxxGk48aI726173e3OvVvd7c17JXjxOWdvTuX9Ff2RV4uwG-_vM--KyLDat5F3KVol0K_5_wAMEkl8M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2829426514</pqid></control><display><type>article</type><title>Prevalence and comorbidities of Sjogren's syndrome patients in the Community of Madrid: A population-based cross-sectional study</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Barrio-Cortes, Jaime ; López-Rodríguez, Juan Antonio ; Gómez-Gascón, Tomas ; Rayo-Gómez, Ángeles ; del Cura-González, Isabel ; Domínguez-Berjón, Felicitas ; Esteban-Vasallo, Dolores ; Chalco-Orrego, Juan Pablo ; Vicente-Rabaneda, Esther ; Baldini, Chiara ; Seghieri, Chiara ; Goules, Andreas V. ; Fotiadis, Dimitrios I. ; Tzioufas, Athanasios G.</creator><creatorcontrib>Barrio-Cortes, Jaime ; López-Rodríguez, Juan Antonio ; Gómez-Gascón, Tomas ; Rayo-Gómez, Ángeles ; del Cura-González, Isabel ; Domínguez-Berjón, Felicitas ; Esteban-Vasallo, Dolores ; Chalco-Orrego, Juan Pablo ; Vicente-Rabaneda, Esther ; Baldini, Chiara ; Seghieri, Chiara ; Goules, Andreas V. ; Fotiadis, Dimitrios I. ; Tzioufas, Athanasios G.</creatorcontrib><description>•SS prevalence varies widely due to geolocation, studied populations, classification criteria and epidemiologic methodologies.•Disease diagnosis may be delayed, omitted, or misclassified as another rheumatic or nonrheumatic disease.•Health care policies facilitate early diagnosis and improve SS management and patients’ quality of life.
To estimate the prevalence, sociodemographic characteristics and comorbidities of Sjogren's syndrome (SS) patients in the Community of Madrid.
A population-based cross-sectional cohort of SS patients was derived from the information system for rare diseases in the Community of Madrid (SIERMA) and confirmed by a physician. The prevalence per 10,000 inhabitants among people aged ≥18years in June 2015 was calculated. Sociodemographic data and accompanying disorders were recorded. Univariate and bivariate analyses were performed.
A total of 4,778 SS patients were confirmed in SIERMA; 92.8% were female, with a mean age of 64.3 (standard deviation=15.4) years. A total of 3,116 (65.2%) patients were classified as primary SS (pSS), and 1,662 (34.8%) as secondary SS (sSS). The prevalence of SS among people aged ≥18 years was 8.4/10,000 (95%Confidence interval [CI]=8.2–8.7). The prevalence of pSS was 5.5/10,000 (95%CI=5.3–5.7), and that of sSS was 2.8/10,000 (95%CI=2.7–2.9), with rheumatoid arthritis (20.3%) and systemic lupus erythematosus (8.5%) being the most prevalent associated autoimmune diseases. The most common comorbidities were hypertension (40.8%), lipid disorders (32.7%), osteoarthritis (27.7%) and depression (21.1%). The most prescribed medications were nonsteroidal anti-inflammatory drugs (31.9%), topical ophthalmic therapies (31.2%) and corticosteroids (28.0%).
The prevalence of SS in the Community of Madrid was similar to the overall prevalence worldwide observed in previous studies. SS was more frequent in women in their sixth decade. Two out of every three SS cases were pSS, while one-third were associated predominantly with rheumatoid arthritis and systemic lupus erythematosus.</description><identifier>ISSN: 1297-319X</identifier><identifier>EISSN: 1778-7254</identifier><identifier>DOI: 10.1016/j.jbspin.2023.105544</identifier><identifier>PMID: 36796581</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Adolescent ; Adult ; Arthritis, Rheumatoid - complications ; Arthritis, Rheumatoid - drug therapy ; Arthritis, Rheumatoid - epidemiology ; Comorbidity ; Cross-Sectional Studies ; Epidemiology ; Female ; Humans ; Lupus Erythematosus, Systemic - complications ; Lupus Erythematosus, Systemic - drug therapy ; Lupus Erythematosus, Systemic - epidemiology ; Male ; Middle Aged ; Prevalence ; Sjogren's syndrome ; Sjogren's Syndrome - complications</subject><ispartof>Joint, bone, spine : revue du rhumatisme, 2023-07, Vol.90 (4), p.105544-105544, Article 105544</ispartof><rights>2023 Société française de rhumatologie</rights><rights>Copyright © 2023 Société française de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-257b4439279097af55163a90149c979dc379077b70f406b360a60ad3912c2c683</citedby><cites>FETCH-LOGICAL-c362t-257b4439279097af55163a90149c979dc379077b70f406b360a60ad3912c2c683</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jbspin.2023.105544$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36796581$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Barrio-Cortes, Jaime</creatorcontrib><creatorcontrib>López-Rodríguez, Juan Antonio</creatorcontrib><creatorcontrib>Gómez-Gascón, Tomas</creatorcontrib><creatorcontrib>Rayo-Gómez, Ángeles</creatorcontrib><creatorcontrib>del Cura-González, Isabel</creatorcontrib><creatorcontrib>Domínguez-Berjón, Felicitas</creatorcontrib><creatorcontrib>Esteban-Vasallo, Dolores</creatorcontrib><creatorcontrib>Chalco-Orrego, Juan Pablo</creatorcontrib><creatorcontrib>Vicente-Rabaneda, Esther</creatorcontrib><creatorcontrib>Baldini, Chiara</creatorcontrib><creatorcontrib>Seghieri, Chiara</creatorcontrib><creatorcontrib>Goules, Andreas V.</creatorcontrib><creatorcontrib>Fotiadis, Dimitrios I.</creatorcontrib><creatorcontrib>Tzioufas, Athanasios G.</creatorcontrib><title>Prevalence and comorbidities of Sjogren's syndrome patients in the Community of Madrid: A population-based cross-sectional study</title><title>Joint, bone, spine : revue du rhumatisme</title><addtitle>Joint Bone Spine</addtitle><description>•SS prevalence varies widely due to geolocation, studied populations, classification criteria and epidemiologic methodologies.•Disease diagnosis may be delayed, omitted, or misclassified as another rheumatic or nonrheumatic disease.•Health care policies facilitate early diagnosis and improve SS management and patients’ quality of life.
To estimate the prevalence, sociodemographic characteristics and comorbidities of Sjogren's syndrome (SS) patients in the Community of Madrid.
A population-based cross-sectional cohort of SS patients was derived from the information system for rare diseases in the Community of Madrid (SIERMA) and confirmed by a physician. The prevalence per 10,000 inhabitants among people aged ≥18years in June 2015 was calculated. Sociodemographic data and accompanying disorders were recorded. Univariate and bivariate analyses were performed.
A total of 4,778 SS patients were confirmed in SIERMA; 92.8% were female, with a mean age of 64.3 (standard deviation=15.4) years. A total of 3,116 (65.2%) patients were classified as primary SS (pSS), and 1,662 (34.8%) as secondary SS (sSS). The prevalence of SS among people aged ≥18 years was 8.4/10,000 (95%Confidence interval [CI]=8.2–8.7). The prevalence of pSS was 5.5/10,000 (95%CI=5.3–5.7), and that of sSS was 2.8/10,000 (95%CI=2.7–2.9), with rheumatoid arthritis (20.3%) and systemic lupus erythematosus (8.5%) being the most prevalent associated autoimmune diseases. The most common comorbidities were hypertension (40.8%), lipid disorders (32.7%), osteoarthritis (27.7%) and depression (21.1%). The most prescribed medications were nonsteroidal anti-inflammatory drugs (31.9%), topical ophthalmic therapies (31.2%) and corticosteroids (28.0%).
The prevalence of SS in the Community of Madrid was similar to the overall prevalence worldwide observed in previous studies. SS was more frequent in women in their sixth decade. Two out of every three SS cases were pSS, while one-third were associated predominantly with rheumatoid arthritis and systemic lupus erythematosus.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Arthritis, Rheumatoid - complications</subject><subject>Arthritis, Rheumatoid - drug therapy</subject><subject>Arthritis, Rheumatoid - epidemiology</subject><subject>Comorbidity</subject><subject>Cross-Sectional Studies</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Humans</subject><subject>Lupus Erythematosus, Systemic - complications</subject><subject>Lupus Erythematosus, Systemic - drug therapy</subject><subject>Lupus Erythematosus, Systemic - epidemiology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prevalence</subject><subject>Sjogren's syndrome</subject><subject>Sjogren's Syndrome - complications</subject><issn>1297-319X</issn><issn>1778-7254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEuL1TAUgIM4OA_9ByLZOZveyTs3LoThMqPCiIIK7kKapJrSJjVpB-7Onz6pHV0KgYRzvvPIB8BLjHYYYXHV7_q2TCHuCCK0hjhn7Ak4w1LuG0k4e1rfRMmGYvX9FJyX0iOEKOHiGTilQirB9_gM_P6c_b0ZfLQemuigTWPKbXBhDr7A1MEvffqRfXxdYDlGl9Po4WRqMs4Fhgjnnx4e0jguMczHlf9oXA7uDbyGU5qWoaIpNq0pvvbOqZSmeLvGzADLvLjjc3DSmaH4F4_3Bfh2e_P18L65-_Tuw-H6rrFUkLkhXLaMUUWkQkqajnMsqFEIM2WVVM7SmpCylahjSLRUIFOPowoTS6zY0wtwufWdcvq1-DLrMRTrh8FEn5aiyZ4oRgTHrKJsQ_8snH2npxxGk48aI726173e3OvVvd7c17JXjxOWdvTuX9Ff2RV4uwG-_vM--KyLDat5F3KVol0K_5_wAMEkl8M</recordid><startdate>202307</startdate><enddate>202307</enddate><creator>Barrio-Cortes, Jaime</creator><creator>López-Rodríguez, Juan Antonio</creator><creator>Gómez-Gascón, Tomas</creator><creator>Rayo-Gómez, Ángeles</creator><creator>del Cura-González, Isabel</creator><creator>Domínguez-Berjón, Felicitas</creator><creator>Esteban-Vasallo, Dolores</creator><creator>Chalco-Orrego, Juan Pablo</creator><creator>Vicente-Rabaneda, Esther</creator><creator>Baldini, Chiara</creator><creator>Seghieri, Chiara</creator><creator>Goules, Andreas V.</creator><creator>Fotiadis, Dimitrios I.</creator><creator>Tzioufas, Athanasios G.</creator><general>Elsevier Masson SAS</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202307</creationdate><title>Prevalence and comorbidities of Sjogren's syndrome patients in the Community of Madrid: A population-based cross-sectional study</title><author>Barrio-Cortes, Jaime ; López-Rodríguez, Juan Antonio ; Gómez-Gascón, Tomas ; Rayo-Gómez, Ángeles ; del Cura-González, Isabel ; Domínguez-Berjón, Felicitas ; Esteban-Vasallo, Dolores ; Chalco-Orrego, Juan Pablo ; Vicente-Rabaneda, Esther ; Baldini, Chiara ; Seghieri, Chiara ; Goules, Andreas V. ; Fotiadis, Dimitrios I. ; Tzioufas, Athanasios G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-257b4439279097af55163a90149c979dc379077b70f406b360a60ad3912c2c683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Arthritis, Rheumatoid - complications</topic><topic>Arthritis, Rheumatoid - drug therapy</topic><topic>Arthritis, Rheumatoid - epidemiology</topic><topic>Comorbidity</topic><topic>Cross-Sectional Studies</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Humans</topic><topic>Lupus Erythematosus, Systemic - complications</topic><topic>Lupus Erythematosus, Systemic - drug therapy</topic><topic>Lupus Erythematosus, Systemic - epidemiology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prevalence</topic><topic>Sjogren's syndrome</topic><topic>Sjogren's Syndrome - complications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Barrio-Cortes, Jaime</creatorcontrib><creatorcontrib>López-Rodríguez, Juan Antonio</creatorcontrib><creatorcontrib>Gómez-Gascón, Tomas</creatorcontrib><creatorcontrib>Rayo-Gómez, Ángeles</creatorcontrib><creatorcontrib>del Cura-González, Isabel</creatorcontrib><creatorcontrib>Domínguez-Berjón, Felicitas</creatorcontrib><creatorcontrib>Esteban-Vasallo, Dolores</creatorcontrib><creatorcontrib>Chalco-Orrego, Juan Pablo</creatorcontrib><creatorcontrib>Vicente-Rabaneda, Esther</creatorcontrib><creatorcontrib>Baldini, Chiara</creatorcontrib><creatorcontrib>Seghieri, Chiara</creatorcontrib><creatorcontrib>Goules, Andreas V.</creatorcontrib><creatorcontrib>Fotiadis, Dimitrios I.</creatorcontrib><creatorcontrib>Tzioufas, Athanasios G.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Joint, bone, spine : revue du rhumatisme</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Barrio-Cortes, Jaime</au><au>López-Rodríguez, Juan Antonio</au><au>Gómez-Gascón, Tomas</au><au>Rayo-Gómez, Ángeles</au><au>del Cura-González, Isabel</au><au>Domínguez-Berjón, Felicitas</au><au>Esteban-Vasallo, Dolores</au><au>Chalco-Orrego, Juan Pablo</au><au>Vicente-Rabaneda, Esther</au><au>Baldini, Chiara</au><au>Seghieri, Chiara</au><au>Goules, Andreas V.</au><au>Fotiadis, Dimitrios I.</au><au>Tzioufas, Athanasios G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence and comorbidities of Sjogren's syndrome patients in the Community of Madrid: A population-based cross-sectional study</atitle><jtitle>Joint, bone, spine : revue du rhumatisme</jtitle><addtitle>Joint Bone Spine</addtitle><date>2023-07</date><risdate>2023</risdate><volume>90</volume><issue>4</issue><spage>105544</spage><epage>105544</epage><pages>105544-105544</pages><artnum>105544</artnum><issn>1297-319X</issn><eissn>1778-7254</eissn><abstract>•SS prevalence varies widely due to geolocation, studied populations, classification criteria and epidemiologic methodologies.•Disease diagnosis may be delayed, omitted, or misclassified as another rheumatic or nonrheumatic disease.•Health care policies facilitate early diagnosis and improve SS management and patients’ quality of life.
To estimate the prevalence, sociodemographic characteristics and comorbidities of Sjogren's syndrome (SS) patients in the Community of Madrid.
A population-based cross-sectional cohort of SS patients was derived from the information system for rare diseases in the Community of Madrid (SIERMA) and confirmed by a physician. The prevalence per 10,000 inhabitants among people aged ≥18years in June 2015 was calculated. Sociodemographic data and accompanying disorders were recorded. Univariate and bivariate analyses were performed.
A total of 4,778 SS patients were confirmed in SIERMA; 92.8% were female, with a mean age of 64.3 (standard deviation=15.4) years. A total of 3,116 (65.2%) patients were classified as primary SS (pSS), and 1,662 (34.8%) as secondary SS (sSS). The prevalence of SS among people aged ≥18 years was 8.4/10,000 (95%Confidence interval [CI]=8.2–8.7). The prevalence of pSS was 5.5/10,000 (95%CI=5.3–5.7), and that of sSS was 2.8/10,000 (95%CI=2.7–2.9), with rheumatoid arthritis (20.3%) and systemic lupus erythematosus (8.5%) being the most prevalent associated autoimmune diseases. The most common comorbidities were hypertension (40.8%), lipid disorders (32.7%), osteoarthritis (27.7%) and depression (21.1%). The most prescribed medications were nonsteroidal anti-inflammatory drugs (31.9%), topical ophthalmic therapies (31.2%) and corticosteroids (28.0%).
The prevalence of SS in the Community of Madrid was similar to the overall prevalence worldwide observed in previous studies. SS was more frequent in women in their sixth decade. Two out of every three SS cases were pSS, while one-third were associated predominantly with rheumatoid arthritis and systemic lupus erythematosus.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>36796581</pmid><doi>10.1016/j.jbspin.2023.105544</doi><tpages>1</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1297-319X |
| ispartof | Joint, bone, spine : revue du rhumatisme, 2023-07, Vol.90 (4), p.105544-105544, Article 105544 |
| issn | 1297-319X 1778-7254 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2829426514 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Adolescent Adult Arthritis, Rheumatoid - complications Arthritis, Rheumatoid - drug therapy Arthritis, Rheumatoid - epidemiology Comorbidity Cross-Sectional Studies Epidemiology Female Humans Lupus Erythematosus, Systemic - complications Lupus Erythematosus, Systemic - drug therapy Lupus Erythematosus, Systemic - epidemiology Male Middle Aged Prevalence Sjogren's syndrome Sjogren's Syndrome - complications |
| title | Prevalence and comorbidities of Sjogren's syndrome patients in the Community of Madrid: A population-based cross-sectional study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T22%3A52%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20and%20comorbidities%20of%20Sjogren's%20syndrome%20patients%20in%20the%20Community%20of%20Madrid:%20A%20population-based%20cross-sectional%20study&rft.jtitle=Joint,%20bone,%20spine%20:%20revue%20du%20rhumatisme&rft.au=Barrio-Cortes,%20Jaime&rft.date=2023-07&rft.volume=90&rft.issue=4&rft.spage=105544&rft.epage=105544&rft.pages=105544-105544&rft.artnum=105544&rft.issn=1297-319X&rft.eissn=1778-7254&rft_id=info:doi/10.1016/j.jbspin.2023.105544&rft_dat=%3Cproquest_cross%3E2829426514%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2829426514&rft_id=info:pmid/36796581&rft_els_id=S1297319X23000234&rfr_iscdi=true |